|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Pamela Johnson, Ph.D. Chief, Applied Research Division Office of Health U.S. Agency for International Development Washington, D.C. Thomas D. Kiley, J.D. Attorney Hillsborough, CA Pierre Lemoine Chief, National Laboratory for Control of Vaccines Ministry of Public Health Brussels, Belgium David Lohr Vice President, Business Development Medisorb Technologies International, Ltd. Cincinnati, OH Richard Mahoney, Ph.D. Vice President and Director Technology Promotion Program for Appropriate Technology in Health Seattle, WA Harry M. Meyer, Jr., M.D. President, Medical Research Division American Cyanamid Co. Pearl River, NY David Mowery, Ph.D. Associate Professor University of California School of Business Berkeley, CA William Packer, C.P.A. President Virus Research Institute Cambridge, MA Timothy D. Proctor, J.D. Associate General Counsel Merck & Co., Inc. Rahway, NJ Philip K. Russell, M.D. Professor, Division of International Health John Hopkins School of Hygiene and Public Health Baltimore, MD Jerald C. Sadoff, M.D. Director Division of Communicable Diseases and Immunology Walter Reed Army Institute for Research Washington, DC Jay P. Sanford, M.D. Dean Emeritus Uniformed Services University of the Health Sciences Dallas, TX Donald Shepard, Ph.D. Professor Institute for Health Policy Brandeis University Waltham, MA Dale Spriggs, Ph.D.1 National Institute of Allergy and Infectious Diseases Bethesda, Maryland
|
|
|||||||||||||||
